exenatide vs tirzepatide Semaglutide vs. Other GLP-1 Receptor Agonists Semaglutide vs Tirzepatide: Which GLP-1

Though it might require patience and persistence, individuals with type 2 diabetes have a range of treatment options available to them and should be confident in their ability to find a medication regime that suits their needs and facilitates their well-being

It is not intended for human or animal consumption, clinical use, diagnostic use, food use, supplement use, cosmetic use, household use, or any application outside of controlled research environments

Across age groups, current GLP-1 use is highest among those ages 50-64 (22%) when compared to younger and older adults

Tirzepatide (Mounjaro) has shown even stronger weight loss results, with an average weight loss of 15-20% in recent trials